Trial
NCT04115956
A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Oncopeptides AB
Collaborators
PRA Health Sciences
Condition
AL Amyloidosis
Intervention
Melphalan-Flufenamide (Melflufen)
Why stopped
The sponsor decided to terminate the study following an FDA request of a partial clinical hold.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-28